TCL Archive In Brief: Bristol Has Change Of Heart, Agrees To Supply NCI With VP-16 Free For Group C Distribution July 16, 1982
TCL Archive Tesetaxel Showed 20 Percent Response In Second-Line Therapy In Phase IIb Trial January 27, 2012
TCL Archive Investigators Unlocking Drug Resistance Secrets, NCI Study, Bristol-Myers Meeting Reports Show November 28, 1986